Hemolytic-Uremic Syndrome and Complement Factor H Deficiency: Clinical Aspects

ABSTRACT

A subgroup of patients with hemolytic-uremic syndrome (HUS) has emerged with complement factor H deficiency. These have come to light because of persistent hypocomplementemia, although the molecular finding by Warwicker et al in one pedigree suggests that not all cases exhibit systemic hypocomplementemia. These patients have an atypical presentation in that they do not consistently have a prodrome of enterocolitis although precipitating factors may include infections of various kinds. Patients usually have severe hypertension early in the course of their illness, tend to relapse, and have a poor prognosis. The age of onset varies from neonates to adults. Plasma exchange and replacement with a plasma product containing factor H seem a reasonable option in the absence of better evidence. Kidney transplantation can meet with recurrence of HUS, but the risk of grafting has yet to be established, and a strategy to overcome graft recurrence is needed. Because of the great rarity of this disorder, a strong case can be made for international registries of atypical HUS cases so that clinical and laboratory investigation is promoted.

KEYWORD

Hemolytic-uremic syndrome - HUS - complement factor H - enterocolitis - hypertension - international registry

REFERENCES

• 1 Milford D V, Taylor C M, Guttridge B. Haemolytic uraemic syndrome in the British Isles 1985-8: association with verocytotoxin producing Escherichia coli Part 1: clinical and epidemiological aspects.  Arch Disease Child . 1990;  65 716-721
• 2 Monnens L, Molenaar J, Lambert P H, Proesmans W, van Munster P. The complement system in hemolytic-uremic syndrome in childhood.  Clin Nephrol . 1980;  13 168-171
• 3 Zipfel P. Complement factor H: Physiology and pathophysiology.  Semin Thromb Hemost . 2001;  27 191-200
• 4 Thompson RA,Winterborn M H. Hypocomplementaemia due to a genetic deficiency of β1H globulin.  Clin Exp Immunol . 1981;  46 110-119
• 5 Vogt B A, Wyatt R J, Burke B A, Simonton S C, Kashtan C E. Inherited factor H deficiency and collagen type III glomerulopathy.  Pediatr Nephrol . 1995;  9 11-15
• 6 Pichette V, Querin S, Schurch W. Familial hemolytic-uremic syndrome and homozygous factor H deficiency.  Am J Kidney Dis . 1994;  24 936-941
• 7 Ohali M, Shalev H, Schlesinger M. Hypocomplementemic autosomal recessive hemolytic uremic syndrome with decreased factor H.  Pediatr Nephrol . 1998;  12 619-624
• 8 Rougier N, Kazatchkine M D, Rougier J-P. Human complement factor H deficiency associated with hemolytic uremic syndrome.  J Am Soc Nephrol . 1998;  9 2318-2326
• 9 Warwicker P, Donne R L, Goodship J A. Familial relapsing haemolytic uraemic syndrome and complement factor H deficiency.  Nephrol Dial Transplant . 1999;  14 1229-1233
• 10 Roodhooft A M, McLean R H, Elst E, Van Acker J K. Recurrent haemolytic uraemic syndrome and acquired hypomorphic variant of the third component of complement.  Pediatr Nephrol . 1990;  4 597-599
• 11 Warwicker P, Goodship T HJ, Donne R L. Genetic studies into inherited and sporadic hemolytic uremic syndrome.  Kidney Int. 1998;  53 836-844
• 12 Farr M J, Roberts S, Morley A R. The haemolytic uraemic syndrome-a family study.  Q J Med . 1975;  44 161-188
• 13 Edelsten A D, Tuck S. Familial haemolytic uraemic syndrome.  Arch Dis Child . 1978;  53 255-256
• 14 Pirson Y, Lefebvre C, Arnout C, Van Ypersele, De Strihou C. Hemolytic uremic syndrome in three adult siblings: a family study and evolution.  Clin Nephrol . 1987;  28 250-255
• 15 Ault B H, Schmidt B Z, Fowler N L. Human factor H deficiency.  J Biol Chem . 1997;  272 25168-25175
• 16 Ying L, Katz Y, Schlesinger M. Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome.  Am J Hum Genet . 1999;  65 1538-1546
• 17 Buddles M RH, Donne R L, Richards A, Goodship J, Goodship T HJ. Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome.  Am J Hum Genet . 2000;  66 1721-1722
• 18 ThoenesW, J ohn. Endotheliotropic (haemolytic) nephroangiopathy and its various manifestations: thrombotic microangiopathy, primary malignant nephro-sclerosis, haemolytic uraemic syndrome.  Klin Wochenschr . 1980;  58 173-184
• 19 Inward C D, Howie A J, Fitzpatrick M M. Renal histopathology in fatal cases of diarrhoea-associated haemolytic uraemic syndrome.  Pediatr Nephrol . 1997;  11 556-559
• 20 Hogasen K, Jansen J H, Mollnes T E, Hovdenes J, Harboe M. Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency.  J Clin Invest . 1995;  95 1054-1061
• 21 Gubler M C, Dommergues J P, Foulard M. Collagen type III glomerulopathy: a new type of hereditary nephropathy.  Pediatr Nephrol . 1993;  7 354-360
• 22 Nanaku M. Complement regulatory proteins in glomerular diseases.  Kidney Int . 1998;  54 1419-1428
• 23 Mathieson P W. Is complement a target for therapy in renal disease?.  Kidney Int . 1998;  54 1429-1436
• 24 Noris M, Ruggenenti P, Perna A. Hypocomplementemia discloses genetic predisposition to hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: role of factor H abnormalities.  J Am Soc Nephrol . 1999;  10 281-293
• 25 Hindmarsh E J, Marks R M. Complement activation occurs on subendothelial extracellular matrix in vitro and is initiated by retraction or removal of overlying endothelial cells.  J Immunol . 1998;  12 6128-6136
• 26 Ichida S, Yuzawa Y, Okada H, Yoshioka K, Matsuo S. Localisation of the complement regulatory proteins in the normal human kidney.  Kidney Int . 1994;  46 89-96
• 27 Nangaku M, Alpers C E, Pippin J. A new model of renal microvascular endothelial injury.  Kidney Int . 1997;  1 182-194
• 28 Nangaku M, Alpers C E, Pippin J. CD59 protects glomerular endothelial cells from immune-mediated thrombotic microangiopathy in rats.  J Am Soc Nephrol . 1998;  9 590-597